Evidence map›Paper›PMID 12228321›Full record

ArticleInfection and immunity2002

A monoclonal antibody to the amebic lipophosphoglycan-proteophosphoglycan antigens can prevent disease in human intestinal xenografts infected with Entamoeba histolytica.

Zhi Zhang, Michael Duchêne, Samuel L Stanley

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Lipids inFrontiers in cellular and infection microbiology · 2020
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Zhi ZhangDepartment of Medicine, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
Michael Duchêne
Samuel L Stanley
University of Vienna · ATWashington University in St. Louis · US

Funding

Washington University DDRCC Supplemental Equipment RequestP30DK052574 · NIDDK · WASHINGTON UNIVERSITY · PI Nicholas O. Davidson · 2000 to 2026
$30.8M
LABORATORY OF DEVELOPMENTAL BIOLOGYR24HD000836 · NICHD · UNIVERSITY OF WASHINGTON · PI Ian Amos Glass · 1995 to 2026
$16.9M
MOLECULAR DISSECTION OF E. HISTOLYTICA PATHOGENESISR01AI030084 · NIAID · WASHINGTON UNIVERSITY · PI STENSON, WILLIAM F. · 1992 to 2010
$3.3M
STUDY OF EMBRYOLOGYR01HD000836 · NICHD · UNIVERSITY OF WASHINGTON · PI FANTEL, ALAN G · 1985 to 1994
–
NIAID NIH HHS AI30084NIAID NIH HHS R01 AI030084NICHD NIH HHS HD00836NICHD NIH HHS R24 HD000836NIDDK NIH HHS DK52574NIDDK NIH HHS P30 DK052574
6 · The paper itself

Abstract

Entamoeba histolytica trophozoites are covered by lipophosphoglycan-peptidoglycan molecules which may be key virulence factors. We found that pretreatment of severe combined immunodeficient mice bearing human intestinal xenografts with a monoclonal antibody to the amebic lipophosphoglycan-peptidoglycan molecules can prevent or significantly reduce the human intestinal inflammation and tissue damage that are normally seen with E. histolytica colonic infection.

Indexed as

AnimalsAntibodies, MonoclonalAntibodies, ProtozoanAntigens, ProtozoanColonDysentery, AmebicEntamoeba histolyticaGlycosphingolipidsHumansImmunization, PassiveMiceMice, SCIDProteoglycansProtozoan ProteinsTransplantation, HeterologousAntibodies, MonoclonalAntibodies, ProtozoanAntigens, ProtozoanGlycosphingolipidslipophosphonoglycanProteoglycansProtozoan Proteins

Identifiers

PMID12228321
PMCPMC128362
OpenAlexW2101332140

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.